Atlas FDA

Coulter Clone B6-FITC Reagent

FDA device recall Z-1071-03 · posted 2003-07-30 · Terminated

Recall details

Recalling firm
Beckman Coulter Inc
Reason for recall
Diminished expression on B-Cell populations when drawn in EDTA tubes, which may lead to inaccurate interpretation of phenotype results. It was determined that choice of anticoagulant may have an effect on results for this reagent. The CD23 clone has shown a diminished expression on B-Cell populations when drawn on EDTA tubes, which may lead to inaccurate interpretation of phenotype results.
Action taken
Customer letters will be sent to all known purchasers on or about 4/28/2003, also existing inventory will be reworked to include a letter describing performance issues when collection occurs using EDTA.
Root cause
Other
Status
Terminated
Quantity affected
122
Distribution
Nationwide and to Canada
Date initiated
2003-04-28
Date posted
2003-07-30
Date terminated
2004-04-20
Location
Brea, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.